Risk for pancreatitis was not elevated among users of tirzepatide relative to placebo, despite the presence of elevated pancreatic enzymes.

Most people have missed a dose of prescription medication at some point. But if you are taking a glucagon-like peptide-1 drug ...

The latest buzz around the popular weight loss drugs Ozempic, Mounjaro and Wegovy is to reduce the doseage to avoid the ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...

Life without a pancreas involves treatments to replace organ function. Learn how different surgical techniques affect overall ...

Viking Therapeutics (VKTX) announced the initiation of a Phase 2 clinical trial of the oral tablet formulation of VK2735, the company’s dual ...

Phase 1 results support proceeding to Phase 2 in patients with post-bariatric hypoglycemia (PBH),which is expected to begin in 2H 2025Phase 1 ...

Dual- and triple-agonist GLP-1s appear to achieve greater weight loss in an overview of clinical trials of approved and ...

Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...

For this review, the authors searched for randomized controlled trials published in MEDLINE, Embase, and Cochrane CENTRAL ...

5 The study was approved by each center’s institutional review board. The dose of corticosteroids was converted to methylprednisolone equivalents. Patients were categorized into low-dose (<60 mg/d), ...